NRx Pharmaceuticals
(NASDAQ) NRXP
NRx Pharmaceuticals Financials at a Glance
Market Cap
$83.00M
Revenue (TTM)
$1.23M
Net Income (TTM)
$28.62M
EPS (TTM)
$-1.57
P/E Ratio
-1.60
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$2.56
Volume
45,059
Open
$2.52
Price
$2.56
Volume
45,059
Open
$2.52
Previous Close
$2.56
Daily Range
$2.50 - $2.58
52-Week Range
$1.62 - $3.84
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$2.56
Volume
45,059
Open
$2.52
Previous Close
$2.56
Daily Range
$2.50 - $2.58
52-Week Range
$1.62 - $3.84
NRXP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NRx Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareCEO
Jonathan C. Javitt, MD
Website
www.nrxpharma.comHeadquarters
Wilmington, DE 19801, US
NRXP Financials
Key Financial Metrics (TTM)
Gross Margin
51%
Operating Margin
-13%
Net Income Margin
-23%
Return on Equity
0%
Return on Capital
1%
Return on Assets
-2%
Earnings Yield
-62.50%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$83.00M
Shares Outstanding
33.07M
Volume
45.06K
Short Interest
0.00%
Avg. Volume
704.47K
Financials (TTM)
Gross Profit
$577.00K
Operating Income
$16.22M
EBITDA
$16.04M
Operating Cash Flow
$14.11M
Capital Expenditure
$0.00
Free Cash Flow
$14.11M
Cash & ST Invst.
$7.80M
Total Debt
$631.00K
NRx Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$983.00K
N/A
Gross Profit
$475.00K
+47600.0%
Gross Margin
48.32%
N/A
Market Cap
$83.00M
N/A
Market Cap/Employee
$41.50M
N/A
Employees
2
N/A
Net Income
$360.00K
+104.0%
EBITDA
$4.49M
+50.5%
Quarterly Fundamentals
Net Cash
$7.17M
+239.6%
Accounts Receivable
$161.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$315.00K
-93.7%
Short Term Debt
$316.00K
-79.8%
Return on Assets
-2.21%
N/A
Return on Invested Capital
1.04%
N/A
Free Cash Flow
$3.71M
-153.6%
Operating Cash Flow
$3.71M
-153.6%